CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
LATEST ALERTS
View all Cannabis and cannabinoids in Florida
News analysis
Global business and regulatory news covering the cannabis industry
Florida bill will not distinguish delta-8 THC from other hemp-derived products
16th December 2021
Blogs |
New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
Daily news alerts
Daily regulatory updates of legal changes in the cannabis sector, including monthly compilations
19th May 2023
US - Florida: Following the recent announcement by organisers of a ballot initiative backed by cannabis company Trulieve that they have collected enough signatures to qualify a legalisation initiative for Florida’s 2024 ballot, Florida attorney general Ashley Moody is petitioning the Florida Supreme Court to opine as to whether the initiative is constitutional in accordance with single-subject requirements and whether the ballot language is clear and unambiguous, press reports. In 2022, Moody made the same argument against a 2022 legalisation measure, consequently resulting in its invalidation by the Supreme Court. However, activists have stated that they have accommodated the validity of the measure and feel confident in the court’s consensus with it.15th May 2023
- US - Florida: House Bill 1387 has been signed by governor Ron DeSantis and enacted into law. The bill will impose stronger child protection provisions on medical cannabis products by prohibiting certain packaging and advertising considered attractive to children.
5th May 2023
- US - Florida: House Bill (HB) 387 has been passed by the Senate and now heads to the governor’s desk. HB 387 would require a physical examination (in person) of a patient for an initial physician certification for medical cannabis and allow for its renewal through Telehealth.
5th May 2023
- US - Florida: House Bill 1387 has been passed by the Senate and now heads to the governor’s desk. It would impose stronger child protection provisions on medical cannabis products by prohibiting certain packaging and advertising considered attractive to children.
3rd May 2023
US - Florida: Senate Bill 1676 has been passed by the House and now heads to the governor’s desk. Among other things, it would prohibit hemp-derived products from using packaging, labelling, marketing, and advertising that is attractive to children and would prescribe penalties for anyone who sells hemp-derived products to under-21s.
2nd May 2023
US - Florida: Senate Bill 1676 has been passed by the Senate and now heads to the House. Among other things, it would prohibit hemp-derived products from using packaging, labelling, marketing, and advertising that is attractive to children and would prescribe penalties for anyone who sells hemp-derived products to under-21s.
2nd May 2023
US - Florida: House Bill 1387 has been passed by the House and now heads to the Senate. It would impose stronger child protection provisions on medical cannabis products by prohibiting certain packaging and advertising considered attractive to children.
28th April 2023
- US - Florida: House Bill (HB) 387 has been passed by the House and now heads to the Senate. HB 387 would require a physical examination (in person) of a patient for an initial physician certification for medical cannabis and allow for its renewal through Telehealth.
20th December 2022
- US - Florida: The Florida Department of Health has issued an emergency rule to allow for a new batch of medical marijuana treatment centres (MMTCs) to be licensed. No timeline for applications has been announced, but the department will issue 22 new MMTC licences, press reports.
1st September 2022
US - Florida: The Florida Department of Health has issued an emergency rule setting limits on daily dosages for medical cannabis under Florida Statute 381.986(4)(f). The daily dosage amount is set by product type as follows: edibles 60 mg THC; vaporisers 350 mg THC; oral products, such as tinctures and capsules 200 mg THC; sublingual products 190 mg THC; suppositories 195 mg THC; topicals 150 mg THC; and smokable cannabis 2.025 g. The daily dosage is multiplied to determine the 70-day supply limit (or 35-day supply limit in the case of smokable cannabis) that physicians can prescribe.
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
